About

Hiroki Hasegawa is a researcher in the Advanced Business Development Division.
He gained a Diploma in Science in 2013 and a Master Degree of Science in 2015 from Osaka University. Since April 2015 he has been working for Mitsubishi Gas Chemical Company, Inc., in charge of macromolecular science, especially in the composition development of thermosetting resin. Since 2018 he has been part of the team developing multilayer plastic vials and syringes for biologics.

Contributions

PREFILLED SYRINGES

OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES

Hiroki Hasegawa and Tomohiro Suzuki provide an overview of the OXYCAPT multilayer vial and syringe, along with a discussion of how OXYCAPT fares at low and very low temperatures.

More contributions

INDUSTRIALISATION

UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE

Hiroki Hasegawa and Tomohiro Suzuki discuss the advantages of OXYCAPT™ multilayer plastic vial and syringe, which combine the benefits of cyclo-olefin polymer with excellent oxygen and UV barrier properties. In particular, the authors focus on recent studies that highlight OXYCAPT’s very low levels of extractables.

WEARABLES

ADVANCES IN MULTILAYER TECHNOLOGY FOR WEARABLE INJECTOR PRIMARY PACKAGING

Hiroki Hasegawa and Tomohiro Suzuki discuss how multilayer technology used in the drinks bottle industry can be used to create syringes and vials for biologics, avoiding problems such as oxidation and absorption that occur with other materials.